Exposure to wildfire smoke may increase the risk of developing several cancers, according to research presented at the AACR...
“Do you want to have fun?” Richard Pazdur, MD, director of the U.S. Food and Drug Administration (FDA) Oncology...
Immune checkpoint inhibitors have become part of the standard of care for more than 14 different cancer types, including...
During the second quarter of 2026, oncology approvals issued by the U.S. Food and Drug Administration expanded the treatment...
The June edition of Editors’ Picks from the AACR journals included studies on targeting neural cross-talk to stop glioblastoma...
In May, AACR's journals editors highlighted studies on CD28’s impact on CAR T-cell activity, the relationship between neurons and...
In April 2026, AACR's journals editors highlighted studies on cancer survivors taking GLP-1 agonists, an immunotherapy-boosting bacteria, and more.
A recap of the last day of the AACR Annual Meeting 2026, including plenaries on innovative treatment modalities and...
A recap of the fourth day of the AACR Annual Meeting 2026, including a plenary on AI, the NCI...
A recap from the second day of the AACR Annual Meeting 2026, including the 5K, clinical trials, Discovery Science...
In March, AACR's journals editors highlighted studies on the development of pediatric leukemia, the use of low-dose tamoxifen, and...